Profile: MedMira Inc. develops & manufactures rapid diagnostics that help healthcare providers, public health agencies, and individuals to prevent & control the spread of infectious diseases like HIV & hepatitis. We offer HIV tests under the brand names Reveal® G3, MiraWell®, MiraCare®, and MedMira®. Our MiraWell® rapid HIV test is designed to detect antibodies to HIV-1 and HIV-2. It can be used in a wide range of testing environments from clinical laboratories to mobile testing clinics. Our MiraWell® HIV laboratory format uses whole blood, serum or plasma specimens and is volume packaged for large scale research & public health testing programs. Our MiraWell® HIV point-of-care format is sold in packages of single test kits with all the necessary components inside one pouch. It uses whole blood, serum or plasma specimens. It is ideal for doctors' offices, mobile testing clinics, resource limited settings and hospitals that require smaller numbers of tests.

The company was founded in 1992, has revenues of USD 1-5 Million, has ~60 employees and is ISO 9001 certified. CVE:MIR (SEC Filings)

FDA Registration Number: 3003595936
US Agent: Ej Smith / Smith Associates
Phone: +1-(410)-451-0639  Fax: +1-(410)-793-0448  E-Mail: